Active Ingredient: IOBENGUANE I-131
Proprietary Name: AZEDRA
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 15mCi/ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N209607
Product Number: 001
Approval Date: Jul 30, 2018
Applicant Holder Full Name: PROGENICS PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
